In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

Actinogen Medical Limited announces that the World Health Organization (WHO) has granted the nonproprietary name of 'emestedastat' to Actinogen for its Xanamem®/UE2343 once-a-day small molecule in ...

Imagine constantly battling with your thoughts, being unable to focus, or needing to move when the world expects you to stay ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal ...

Three people with a muscle-destroying disease destined to worsen got a little stronger when an implanted device zapped their ...

Today, quip, the pioneering design-led oral wellness company, is proud to announce the launch of its groundbreaking innovation: the quip Ultra Next Generation Smart Sonic Toothbrush. Designed in ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has ...

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...

Abstract Research of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia (FM), two acquired chronic illnesses affecting mainly females, has failed to ascertain their frequent ...

The FDA has approved Onapgo, the first subcutaneous apomorphine device to treat motor fluctuations in adults with Parkinson’s disease, according to the manufacturer.In a press release, Supernus ...